Please login to the form below
New Accounts: March
The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period January 2006 to February 2006 inclusive
The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period January 2006 to February 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
|
|
 |
 |
 |
|
Astellas |
Pan-European corporate profiling |
Corporate |
The Choice Group |
|
AstraZeneca |
Crestor |
Cardiovascular |
Zaicom MMC |
|
Boehringer Ingelheim/Lilly UK |
Cymbalta |
Neurology |
Virgo Health PR |
|
Cephalon |
Actiq |
Pain |
TVF Communications |
|
GE Healthcare Europe |
DaTSCAN |
Diagnostic/neurology |
Succinct Communications |
|
GlaxoSmithKline |
Kivexa |
HIV |
90TEN Healthcare |
|
GlaxoSmithKline |
New product |
Oncology |
Succinct Communications |
|
Novartis |
Aclasta |
CRM |
MRM Worldwide |
|
Novartis |
Diovan/Codiovan |
Hypertension |
TVF Communications |
|
Novartis |
OTC |
Skincare products |
Toniq |
|
Novartis |
Prexige |
Osteoarthritic pain |
Clew Communications |
|
Pfizer |
5th Ann Meet of Institute of Arthritis & Pain |
Arthritis and pain |
Zaicom MMC |
|
Pfizer |
Diovan/Codiovan |
Hypertension |
TVF Communications |
|
Pfizer |
Vfend |
Haematology |
Zaicom MMC |
|
Sankyo |
Olmetec |
Hypertension |
Athena Medical PR |
|
UCB Pharma |
Equasym XL |
ADHD |
TVF Communications |
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
Senior Account Manager
-
Competitive salary offered
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- US demand for COVID-19 antibody treatments rising fast
- EU “still interested” in Valneva COVID vaccine despite UK snub
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Biogen's ALS drug tofersen misses phase 3 endpoint
- Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence
- Valneva COVID-19 vaccine more effective than AZ
- Real-world data highlights flu vaccine efficacy
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
- Best practice in UK diabetes care recognised at prestigious national awards
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Beyond yoga and smoothies – providing real support for employee well-being
- The Future of eHealth: Contactless Health Monitoring
- How do you define a biotech company?
- Attracting the best talent to build Lucid’s future
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
PMHub
KVA Digital
KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...
Latest intelligence
- Breaking the silence: It’s time to talk about the menopause
- Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
- Committing time to making meaningful connections - top 5 tips
- Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
- News:
- Senior Analytics Specialist joins Research Partnership...
